IL17A and pancreatic ductal adenocarcinoma: To understand how the metabolic status may influence the functional activity of macrophages, and particularly their ability to take-up damaged cells, we tested the phagocytosis of gemcitabine-treated Pancreatic Ductal Adenocarcinoma (PDAC) cells stained with the cell-tracking CFSE in WT and IL17A−/−-derived cells.